MNOV - MediciNova Inc logo

MNOV

MediciNova Inc

MediciNova Inc. develops small molecule therapeutics targeting neurological disorders like ALS and metabolic diseases, focusing on unmet medical needs. Its pipeline includes MN-166 for neuroprotection and MN-001 for fibrotic conditions, enhancing patient care.

โš•๏ธ Healthcare NASDAQ Listed 2005 $ USD
$1,000 invested 10 years ago โ†’$276today

Score Overview

1 Year
Score
Net Growth10.38%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth124.70%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.9
Net Growth-6.11%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-77.20%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth1.04%
Net Trend40%
Net Income Consistency
Rev Growthโ€”
Rev Trend50%
Revenue Consistency
20 Years
Score3.2
Net Growth69.87%
Net Trend55%
Net Income Consistency
Rev Growth248.83%
Rev Trend47%
Revenue Consistency
All Time
Score
Net Growth58.15%
Net Trend52%
Net Income Consistency
Rev Growth14.48%
Rev Trend44%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where MediciNova Inc has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • MNOV

2016: 86.2% ยท 2017: 82.8% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 2.10โ€”
1 Year2025-09-26
$ 1.2765.35%
5 Years2021-09-28
$ 3.91-46.29%
10 Years2016-09-28
$ 7.61-72.40%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 920.48K-$ 10M$ 25.41B
2025$ 409.66K-$ 11M$ 30M
2024$ 0.00-$ 11M$ 40M
2023$ 1M-$ 8M$ 50M
2022$ 0.00-$ 14M$ 58M
2021$ 4M-$ 10M$ 71M
2020$ 4M-$ 13M$ 60M
2019$ 0.00-$ 12M$ 63M
2018$ 0.00-$ 14M$ 62M
2017$ 0.00-$ 11M$ 27M
2016$ 0.00-$ 10M$ 24M
2015$ 0.00-$ 8M$ 22M
2014$ 0.00-$ 9M$ 11M
2013$ 6M-$ 4M$ 6M
2012$ 802.58K-$ 10M$ 4M
2011$ 0.00-$ 17M$ 15M
2010-$ 20M$ 28M
2009-$ 20M$ 46M
2008-$ 21M$ 19M
2007-$ 48M$ 70M
2006$ 263.88K-$ 35M$ 104M
IPO2005$ 804.07K-$ 25M$ 138M
MNOV - MediciNova Inc logo

MediciNova Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 4M to $ 409.66K and net income went from -$ 13M to -$ 11M. Revenue increased in 3 of those 5 years; net income in 2.

Between 2005 and 2025, revenue declined from $ 804.07K to $ 409.66K and net income went from -$ 25M to -$ 11M. Revenue increased in 9 of those 20 years; net income in 11.

MediciNova Inc currently holds a 20-year HDB Score of 3.2 out of 10. How the HDB Score is calculated.

Membership

Continue MNOVโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies